Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
178 hedge funds and large institutions have $792M invested in Impax Laboratories, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 75 increasing their positions, 47 reducing their positions, and 44 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 47
43% more call options, than puts
Call options by funds: $2.75M | Put options by funds: $1.93M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $795M → $792M (-$3.15M)
10% less funds holding
Funds holding: 198 → 178 (-20)
30% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$131M |
| 2 |
Millennium Management
New York
|
+$26.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.5M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$13.4M |
| 5 |
SIG
Senator Investment Group
New York
|
+$13.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hound Partners
New York
|
-$58.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$28.8M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$16.9M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$15.9M |
| 5 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$13.6M |
IPXL Hedge Fund Activity: Q1 2017 in Review
178 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q1 2017, worth a combined $792M — down 0.4% from $795M a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of IPXL and 31 opened new positions — a net loss of 13 holders — while 47 trimmed existing stakes and 75 added.
The largest buyer was BlackRock, adding an estimated $131M. The largest seller was Hound Partners, exiting entirely with an estimated $58.8M sold.
- 178 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q1 2017, down from 198 in Q4 2016.
- Funds reported $792M of Impax Laboratories, Inc. stock for Q1 2017, down 0.4% quarter-over-quarter.
- 31 funds opened new Impax Laboratories, Inc. positions in Q1 2017 and 44 closed out, a net change of -13 holders.
- The largest Impax Laboratories, Inc. buyer in Q1 2017 was BlackRock, an estimated $131M added.
- The largest Impax Laboratories, Inc. seller in Q1 2017 was Hound Partners, an estimated $58.8M sold.
Based on aggregated 13F filings for Q1 2017.